Avery Therapeutics is a preclinical-stage company, developing advanced therapies for patients suffering from cardiovascular diseases, with the vision of being a leader in next-generation bioengineered therapeutics. Avery’s mission is to develop innovative treatments to address large unmet medical needs and improve human quality of life. Avery’s lead candidate is a tissue engineered cardiac graft, MyCardia™, in development for treatment of chronic heart failure.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Arizona
Company HQ Country:
United States
Year Founded:
2014
Main Therapeutic Focus:
Lead Product in Development:
MyCardia
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
